NOC Extends Its Post-Earnings Rally Into a Second Report

Northrop Grumman gained 6.1% last week, a result that puts it well ahead of its closest defense peers: LMT rose 9.4%, but RTX fell 1.5%, LHX added just 2.2%, and GD gained 1.5%, leaving the median peer move at roughly flat. NOC's short interest is a modest 1.6% of free float, one of the lighter readings across the group, and borrow availability is effectively uncapped with no material pressure on the lending side.

The week's move builds on the post-Q3 surge covered in the previous note. The stock jumped more than 11% after its October 20 results, and the analyst community that spent the prior fortnight cutting targets reversed course immediately. Five firms raised targets on October 21 alone. Morgan Stanley lifted to $765, Baird upgraded outright to Outperform with a $675 target, and BNP Paribas moved to $600. Now, just nine days later, the earnings calendar has turned over: the October 29 event listed in the data appears to be a new reporting date, and the stock goes in at $551.44, roughly 14% above where it was when the bulk of those cautious analyst notes landed. The consensus mean price target is $632, implying about 15% further upside from current levels, though Barclays remains at Underweight with a $430 target, holding the most bearish position on the Street.

The fundamental debate has not changed shape. Morgan Stanley's Overweight at $765 and Guggenheim's Buy at $640 anchor the constructive side, where the case rests on B-21 and Sentinel transitioning from development to production, a Defense Systems backlog approaching $35 billion, and the prospect of better margins from international mix and production scale. Against that, Barclays at $430 and RBC at Sector Perform with a $550 target reflect concern that fixed-price LRIP losses on B-21, the Sentinel restructuring overhang, and an executive order limiting capital deployment cap both earnings growth and any premium multiple. The $335 spread between the most bullish and most bearish price targets on the Street is wide enough to make the consensus mean a fairly blunt instrument. Options positioning offers little directional read: the put/call ratio at 1.09 is almost exactly in line with its 20-day average of 1.10, a z-score of essentially zero, suggesting neither unusual hedging nor unusual optimism heading into the print.

One piece of company-specific data adds texture without pointing in a clean direction. SEC EDGAR buyback filings, tracked by the ORTEX Alt Data layer, show NOC repurchased just 100,000 shares in Q1 2026, down roughly 90% year on year, continuing a streak of four consecutive quarterly declines. The new executive order restricting capital deployment, cited by bears as a key overhang, appears to be the operative factor, and this trend will be worth watching in the Q3 disclosure.

The October 29 print will test whether NOC can sustain the margin and revenue trajectory that prompted last week's analyst upgrades, or whether the B-21 cost profile and buyback pullback reassert themselves as the dominant narrative for the stock at current levels.